|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2002;73:1141-1142
© 2002 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria
e-mail: michael.grimm{at}akh-wien.ac.at
Doctor Palma and his associates have provided a remarkable presentation of their 5-year experience with interventional management of aneurysms of the descending aorta. Within this timeframe, the authors have developed and adopted technical approaches that have helped them generate excellent clinical results.
Although great improvements have been made during past years by new surgical approaches, mortality and morbidity related to surgical repair of descending aortic aneurysms remains substantial. The role of catheter-based intraluminal stent grafting in descending aortic aneurysms is currently undergoing active clinical investigation [1]. In the high-risk, clinical setting of endoluminal stent repair of aortic dissection, this new therapeutic approach is yielding extremely promising results. In a recent review of 464 patients with aortic dissection, 30-day mortality in Type B dissection was 11% and 31% for medical or surgical therapy, respectively [2]. Long-term survival with medical therapy ranges around 70% and persistent false lumen patency turns out to be among the most important predictors of late mortality [3]. By noninvasive stent placement the intimal flap is covered and the entry site into the false lumen is obliterated, which results in thrombosis of the false lumen.
In comparison to these "classic" outcomes the authors report a significant step in improving the prognosis of these selected patients. Exclusion of the false lumen and elimination of the most important predictor of late mortalitywas successful in 92% of the patients. Conversion to surgery occurred in 5 patients and procedure-related surgical mortality was 2.8%. Remarkably, 48% of patients required additional stent placement to overcome residual leakage. Nevertheless, in this exceptional series no patient developed paraplegia. Additional complications related to the intervention were stroke or the need for vascular surgery to treat stent-related problems. One might argue that the complications described in the present paper would not occur if patients were only treated medically.
Permanent exclusion of the false lumenresulting in elimination of the main prognostic factor for adverse outcomeseems to justify a certain number of adverse events related to aggressive interventional therapy in the very early period of disease. Long-term follow-up data are needed to verify this theory. Nevertheless, I believe that in descending aortic aneurysms reduction of mortality and especially morbidity by intraluminal stent graft-ing in comparison to surgery is among the most impressive improvements in medicine during the last decade.
References
Related Article
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |